DNLI Markets Signal, Research & Overview

Timing · 1D

Technicals

Summary

Buy

72

5 5 17

Oscillators

Neutral

55

2 5 3

Moving averages

Strong Buy

82

3 0 14

Indicator details →

Signal & events

Model signalUnavailable

EarningsAug 6, 2026

CatalystsData pending

Signal history →Earnings & events →

Company data

Fundamentals

Full fundamentals →

Valuation

Market Cap$3.65B

Growth and income

Eps-2.88

Free Cash Flow$-190.33M

Net Income$-128.45M

Profitability

Ebitda$-531.76M

Balance sheet

Free Cash Flow$-190.33M

Total Assets$1.27B

Total Liabilities$339.93M

Dividends

Payout Ratio0.00%

Trailing Annual Dividend Rate0

Trailing Annual Dividend Yield0.00%

Financial statements →Valuation history →Ownership & capital →

Observed associations

Relationships

View all →

VIRVIR BIOTECHNOLOGY INC+0.00%Market co-movement · Residual co-movement PCVXVAXCYTE INC+0.00%Market co-movement · Residual co-movement RXRXRECURSION PHARMACEUTICALS A+0.00%Market co-movement · Residual co-movement RGNXREGENXBIO INC+0.00%Market co-movement · Residual co-movement BEAMBEAM THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement

RelationshipsLoading

DENALI THERAPEUTICS INC

Quick Read

Technicals

Fundamentals

Valuation

Growth and income

Profitability

Balance sheet

Dividends

Relationships

Relationships